Biogen Idec is another top stock to buy on Wall Street. Many analysts see the company as the most catalyst-rich in the biotech universe, with the most upside versus downside on three specific events this year, including Tysabri SPMS, Alzheimer's and the continued impressive LINGO Phase 2 data.